HONG KONG--(BUSINESS WIRE)--Biofield Corp. (OTC: BZET) today reported that its master licensee, MacKay Group Limited (MKG), will consummate the Chinese healthcare joint ventures with the authorized agent for Shanghai Jiashen Lifecare Investment Management Company Limited (CareLife) on June 16 at a signing ceremony covered by media in mainland China and Hong Kong. A lease has been signed for a new China HQ at an exclusive government owned building in Shanghai. The new China HQ will oversee and manage the Carelife JVs, which will distribute, test, further develop, and gather critical medical data from the Biofield Diagnostic System (BDS) and other medical technology in conjunction with leading Chinese governmental healthcare organizations, hospitals, testing centers, doctors, medical organizations, insurance companies, and banks.
